Literature DB >> 21481946

Are CYP1A2*1F and *1C associated with clozapine tolerability?: a preliminary investigation.

Emilio Bolla, Paola Bortolaso, Marco Ferrari, Nicola Poloni, Camilla Callegari, Franca Marino, Sergio Lecchini, Simone Vender, Marco Cosentino.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21481946     DOI： 10.1016/j.psychres.2011.03.011

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN： 0165-1781            Impact factor:   3.222


× No keyword cloud information.
  7 in total

1.  Oral Antipsychotic Versus Long-Acting Injections Antipsychotic in Schizophrenia Spectrum Disorder: a Mirror Analysis in a Real-World Clinical Setting.

Authors:  Nicola Poloni; Marta Ielmini; Ivano Caselli; Giulia Lucca; Alessandra Gasparini; Alessandra Gasparini; Giorgia Lorenzoli; Camilla Callegari
Journal:  Psychopharmacol Bull       Date:  2019-06-20

2.  6 Weeks Monotherapy with Antipsychotic Drug Reduced Inflammatory Markers in Bipolar Disorder Patients.

Authors:  Marco Ferrari; Marco Godio; Camilla Callegari; Marco Cosentino; Franca Marino
Journal:  Psychopharmacol Bull       Date:  2022-05-31

3.  Efficacy and Tolerability of Two Different Kinds of Titration of Paroxetine Hydrocloride Solution: an Observational Study.

Authors:  Marta Ielmini; Nicola Poloni; Ivano Caselli; Lucia Bianchi; Marcello Diurni; Simone Vender; Camilla Callegari
Journal:  Psychopharmacol Bull       Date:  2018-03-13

4.  Long Acting Injectables and their Correlation with Subjectivity in Schizophrenia Spectrum Disorder.

Authors:  Ivano Caselli; Alessandra Gasparini; Marta Ielmini; Giulia Lucca; Stefano Amorosi; Nicola Poloni; Camilla Callegari
Journal:  Psychopharmacol Bull       Date:  2021-06-01

5.  CYP1A2 polymorphism -1545C > T (rs2470890) is associated with increased side effects to clozapine.

Authors:  Merja Viikki; Olli Kampman; Niko Seppälä; Nina Mononen; Terho Lehtimäki; Esa Leinonen
Journal:  BMC Psychiatry       Date:  2014-02-20       Impact factor: 3.630

6.  Pharmacogenetic Tests in Reducing Accesses to Emergency Services and Days of Hospitalization in Bipolar Disorder: A 2-Year Mirror Analysis.

Authors:  Camilla Callegari; Celeste Isella; Ivano Caselli; Nicola Poloni; Marta Ielmini
Journal:  J Pers Med       Date:  2019-04-30

7.  The utility of pharmacogenetic testing to support the treatment of bipolar disorder.

Authors:  Marta Ielmini; Nicola Poloni; Ivano Caselli; Jordi Espadaler; Miquel Tuson; Alessandro Grecchi; Camilla Callegari
Journal:  Pharmgenomics Pers Med       Date:  2018-03-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.